Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients

被引:6
|
作者
Baer, JT
Sauer, WH
Berlin, JA
Kimmel, SE
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Med, Ctr Educ & Res Theraeut, Philadelphia, PA 19104 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 04期
关键词
D O I
10.1016/j.amjcard.2004.04.063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have slightly different mechanisms of action. As such, it has been hypothesized that these 2 classes of medications differ in their ability to prevent myocardial infarction. In the present case-control study, we found no difference between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of nonfatal myocardial infarction among patients with hypertension. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:479 / 481
页数:3
相关论文
共 50 条
  • [31] Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction
    Sauer, WH
    Baer, JT
    Berlin, JA
    Kimmel, SE
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (09): : 1171 - 1173
  • [32] Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis
    Reboldi, Gianpaolo
    Angeli, Fabio
    Cavallini, Claudio
    Gentile, Giorgio
    Mancia, Giuseppe
    Verdecchia, Paolo
    JOURNAL OF HYPERTENSION, 2008, 26 (07) : 1282 - 1289
  • [33] Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?
    Teo, Koon K.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (1-2): : 8 - 10
  • [34] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers - Reply
    Healey, JS
    Morillo, CA
    Connolly, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 890 - 891
  • [35] Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
    Caldeira, Daniel
    David, Claudio
    Sampaio, Cristina
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 263 - 277
  • [36] The role of angiotensin receptor blockers and/or angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases
    Marin, I
    Madrid, A
    Escobar, C
    Bernal, E
    Rebollol, JMG
    Moreno, G
    Rondon, J
    Moro, C
    EUROPEAN HEART JOURNAL, 2004, 25 : 62 - 62
  • [37] EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN THE CENTRAL BLOOD PRESSURE IN HYPERTENSIVE TREATED
    Barbosa, E.
    Fagundes, R.
    Trarbach, L.
    Finkler, B.
    Eibel, E.
    Sebba-Barroso, W.
    JOURNAL OF HYPERTENSION, 2019, 37 : E173 - E173
  • [38] Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison
    Roberto Robles, Nicolas
    Romero, Baldomero
    Fernandez-Carbonero, Enrique
    Sanchez-Casado, Emilio
    Jose Cubero, Juan
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2009, 10 (04) : 195 - 200
  • [39] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertensive African Americans
    Narayan, P
    Papademetriou, V
    Kokkinos, P
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 166A - 166A
  • [40] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491